Charles Elliott Sigal Buys $244K of Alnylam Pharmaceuticals Inc (ALNY) — SEC Form 4, Nov 12, 2026
Equity Position
5.05K sh
3,446 → 5,046
Equity Change
+46.4%
shares held after vs before
Insider Cluster
2 buying
within 30 days — view cluster
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Charles Elliott Sigal CIK 0001661908 |
Director
|
Charles Elliott Sigal at Alnylam Pharmaceuticals Inc
Full insider history
Bought (12 mo)
$243,600
Sold (12 mo)
—
More from this insider at Alnylam Pharmaceuticals Inc
| 2026-05-22 | Award | — | View |
| 2025-05-12 | Award | — | View |
| 2024-05-20 | Award | — | View |
| 2023-05-19 | Award | — | View |
| 2022-08-24 | Award | — | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-11-10 | P - Purchase | 1,600 A | $152.25 | +$243,600 | 3,600 | Indirect by Trust |
Non-Derivative Holdings
| Title | Shares Held | Ownership |
|---|---|---|
| Common Stock | 1,446 | Direct |
Footnotes (1)
- F1
- Shares held by Sigal Family Investments, LLC, of which the reporting person is Managing Member. Show more
Related filings at Alnylam Pharmaceuticals Inc
Institutional Holders
13F holders · Sep 30, 2026
721
institutional managers reporting a position
Largest by reported value
- Capital World Investors $3.41B
- Fmr Llc $3.11B
- Black Rock, Inc. $2.72B
5%+ Holders · 13D/G
6 filers
Other insiders at Alnylam Pharmaceuticals Inc
GET /v1/forms/4/0001178670-26-000087
API docs
View Original SEC Filing